The Atrophic Scar Treatment Market, in the next 10 years, is expected to substantiate. Hospital decision support solutions are being floated, and the status quo is expected to stay the same even going forward. Herein, value propositions are made to the society on the whole and patients in particular by the government, private insurance companies, and social security organizations working in unison. As such, the healthcare industry is expected to witness a good number of clinical outcomes in the forthcoming period.
According to a recently conducted research by Persistence Market Research titled “Atrophic Scar Treatment Market: Global Industry Analysis 2012 – 2016 and Forecast 2017 – 2025,” the global atrophic scar treatment market is expected to witness moderate growth during an eight-year forecast period 2017-2025. Over the assessment period, the market is likely to thrive at a CAGR of 4.6%. In 2017, global sales of atrophic scar treatments registered revenue worth a value of US$ 4.65 Bn in 2017, which is anticipated to reach beyond US$ 6.5 Bn by the end of 2025.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/22468
“Popularity of lasers and injectables will surge over the years, compared to other product types such as topical scar products and surface treatment. Although topical scar products will retain dominance during 2017-2025 with more than 50% market value share, a gradual decline can be observed with time. While laser therapy is foreseen to emerge popular among wealthy consumers, injectable products will also witness a positive market outlook. Higher treatment costs will persist as a major adoption challenge though”, reports a healthcare market research analyst at Persistence Market Research.
Company Profiles:
- Merz Inc.
- Enaltus LLC
- Oculus Innovative Sciences Inc.
- CCA Industries Inc.
- Cynosure Inc.
- LUMENIS
- Syneron Medical Ltd.
- NutraMarks Inc.
- Mölnlycke Health Care
- Pacific World Corporation
- Valeant Pharmaceuticals International Inc
- Shanghai Fosun Pharmaceuticals Ltd(ACAlma Lasers)
- Beijing Toplaser Technology Co. Ltd
- Sonoma Pharmaceuticals Inc.
- Others.
Get A Customized Scope To Match Your Need Ask An Expert – sales@persistencemarketresearch.com
When it comes to end-user analysis, hospitals are expected to remain dominant with over 35% market value share in 2025. Clinics and pharmacies and drug stores are anticipated to witness stable growth, whereas E-Commerce is likely to emerge popular owing to increasingly growing adoption of online technologies by consumers worldwide.
In addition to growing demand for atrophic scar treatment, the market will experience a major thrust from the changing regulatory landscape in both developed and developing countries. Growing prevalence of skin disorders, increasing demand for sophisticated treatments, persistent product innovations, higher preference for personal care, and surging demand for age-defying treatments are also identified to predominantly fuel revenue growth of the global atrophic scar treatment market.
The regional assessment of global atrophic scar treatment market indicates continued dominance of the North America regional market, followed by Asia Pacific and Europe. By the end of 2025, the North America market for atrophic scar treatment is foreseen to exceed a value of US$ 2.6 Bn. APAC will be led by China, India, and Japan, whereas the Latin America market will be spearheaded by Brazil. Latin America is expected to emerge as the fastest growing regional market for atrophic scar treatment in the coming years.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/22468
Key insights
- The global market value for atrophic scar treatment is expected to register 1.3x growth during 2017-2025
- Topical scar treatment products may lose popularity gradually, owing to growing consumer preference for laser therapies and injectable products
- North America’s dominance is expected to prevail; however, Latin America will witness the fastest growth
Read More Trending “PMR Exclusive Article”-
Treatment Syndromes Dementia Movement Disorders Market–Treatment Syndromes Dementia Movement Disorders Market Segmented By Progressive Dementia, Neurological Abnormalities, Disorder Syndrome
Peripherally Inserted Central Catheters Market–Peripherally Inserted Central Catheters Market Segmented Power Injected, Conventional Peripherally Inserted Central Catheter in Single Lumen, Double Lumen, Multi Lumen Design
About Us: Persistence Market Research
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com